Effie Tozzo Email & Phone Number
Chief Scientific Officer @ Avilar Therapeutics
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Effie Tozzo Location
- Waltham, MA, US
Effie Tozzo Work
- Chief Scientific Officer @ (November 2021 - Present)
- Member Board Of Directors @ (July 2022 - Present)
- Senior Vice President, Drug Development @ (April 2020 - November 2021)
- Senior Vice President, Translational Sciences @ Mitobridge, Inc. (June 2014 - April 2020)
- Director, Diabetes and Endocrinology Research @ (March 2011 - June 2014)
- Senior Research Leader, Group Leader In vivo Pharmacology in Metabolic and Renal Diseases @ (July 2005 - March 2011)
- Senior Principal Scientist Diabetes Group @ (December 2003 - June 2005)
- Head in vivo Pharmacology Metabolic Diseases @ (October 2001 - October 2003)
- Senior Scientist Metabolic Diseases @ Chiron Corporation (September 1999 - September 2001)
- Research Scientist @ (June 1995 - November 1997)
Effie Tozzo Education
- Harvard Medical School
postdoctoral training (diabetes-obesity-focus on fat specific overexpression of Glut4)
1992-1995 - Paris-Sud University (Paris XI)
PhD (Molecular and Cellular Endocrinology-focus on Insulin Receptor regulation in rodent pathophysiology)
1987-1992
Effie Tozzo Skills
- Drug Discovery
- Pharmacology
- Diabetes
- In Vivo
- Biomarkers
- Metabolism
- Drug Development
- Animal Models
- Life Sciences
- Translational Medicine
- Inflammation
- Endocrinology
- Biochemistry
- Clinical Trials
- Pharmaceutical Industry
- Pharmacokinetics
- Science
- Lifesciences
- Physiology
- Biotechnology
- Metabolic Diseases
- Large animal pharmacology
- In-licensing evaluation
- Obesity
- Diabetic nephropathy
- People Development
- Academic collaborations
- Cross-functional Coordination
- Project Coordination
- Exercise Physiology
- Muscle Diseases
- Mitochondrial Function
- NHP models
- Cross Functional Coordination
- Strategic Planning
- Molecular Biology
- Microsoft Excel
- Management
- In Licensing Evaluation
- Analysis
- HIV
- Logic Synthesis
- Pan
- Market
- Vascular
- Languages
- Financial Advisory
- Laboratory
- Localization
- Weight Loss
- Portfolio
- Responsibility
- Pipelines
- Transcription
- Windows
- Primates
- Resource Allocation
- IACUC
- Screening
- Regulations
- Europe
- siRNA
- Characterization
- Sensitivity
- Gamma
- Written
- Concentrations
- Credentials
- Small Molecules
- Acting
- Transgenic Mice
- International
- Biostatistics
- Consideration
- China
- Mechanism of Action Studies
- Pharmaceutical Research
- DNA
- Voting
- Road
- Louisiana
- Clinical Research
- Exp
- In Licensing
- Transporters
- Molecular
- Human Resources
- Training
- Evidence
- Key Opinion Leaders
- Business Expansion
- Us Patent
- Receptors
- Public Speaking
- Glucose
- Seminars
- Scientists
- Cardiovascular Disease
- Recruiting
- Hospitals
- Jenkins
- Structure
- Image Analysis
- Injury
- Staff Development
- Decision Making
- Project Management
- Cros
- Pathophysiology
- Hiring
- Nutrition
- Assessment
- Project Leadership
- Progression
- Renal
- Raman
- Annual Planning
- Disposal
- Mouse
- Parker
- Translation
- Acid
- Facilities Management
- Tissue
- Activator
- Rex
- Conflict Management
- European Union
- Contractual Agreements
- Insulin Resistance
- Lead Change
- Meetings
- Tao
- Insulin
- Treatment
- English
- Sourcing
- Polymorphism
- Symposia
- Summit
- Research
- Sun Microsystems
- Macro
- Diet
- Data Driven Testing
- Franchising
- Writing
- Circadian Rhythms
- Bing
- Education/Training
- Advocate
- Biology
- Validation
- Differentiation
- Wang
- Resistance
- Central Nervous System
- Kidney
- French
- Hla
- France
- Fibrosis
- CAP
- Building Management Systems
- Antibodies
- Boston
- Natural Resources
- Paris
- Ex Vivo
- IV
- Active
- Publications
- Presentations
- Efficacy
- Liver
- Expression
- ePub
- Biologics
- Google Groups
- Funk
- Coordinated
- Coordination
- Conceptual Modeling
- Ping
- Department Reorganization
- C
- Performance Management
- Leadership
- American
- Greek
- Mandarin
- Endocrine
- Baton
- Customer Service
- Sop
- Kidney Disease
- German
- Autodesk Inventor
- Correlations
- Rflp
- Home
- Resume
- Peptides
- Qualification
- Immunology
- Roadmap
- Proposal Writing
- Patents
- Clinical Development
- Strategy
- Disruption
- Platforms
- Metabolic Syndrome
- Project
- Students
- Press
- Microsoft Project
- Diabetic
- Evaluation
- Rats
- Muscle
- Networking
- Conventional
- Medicine
- Ras
- Due Diligence
- Committees
- Cell
- Weaning
- Hp Enterprise Solutions
- Class Ii
- Fat
- Dec Alpha
- Nephrology
- Composition
- London
- Families
- Budgets
- R
- Academic
- Gene Expression
- Mechanisms
- Business Partnering
- Tolerance
- Thesis
- Int
- Design
- Israel
- Cellular Communications
- Flier
- Acute Kidney Injury
- CRO Management
- Ind Enabling
Effie Tozzo Summary
- Effie Tozzo, based in Waltham, MA, US, is currently a Chief Scientific Officer at Avilar Therapeutics. Effie Tozzo brings experience from previous roles at CohBar, Inc., Cellarity, Mitobridge, Inc. and Merck. Effie Tozzo holds a 1992 - 1995 postdoctoral training in diabetes-obesity-focus on fat specific overexpression of Glut4 @ Harvard Medical School. With a robust skill set that includes Drug Discovery, Pharmacology, Diabetes, In Vivo, Biomarkers and more. Effie Tozzo has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Effie Tozzo?
Find contact details for 700 million professionals.
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co